Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...
Alcyone’s License and Collaboration Agreement with Biogen Inc.
Alcyone Therapeutics’ $23 million Funding Round
Foley Hoag advised Alcyone Therapeutics on the deal. Alcyone Therapeutics, a Lowell, Massachusetts-based biotechnology company pioneering next-generation precision central nervous system (CNS) therapies, closed $23 million in...